Rewiring Host-microbe Interactions and Barrier Function During Gastrointestinal Inflammation

Overview

Journal Gastroenterol Rep (Oxf)

Specialty Gastroenterology

Date 2022 Mar 16

PMID 35291443

Authors

Sune K Jensen

Simone I Paerregaard

Emma P Brandum

Astrid S Jorgensen

Gertrud M Hjorto

Benjamin A H Jensen

Affiliations

Soon will be listed here.

Abstract

Organismal survival depends on a well-balanced immune system and maintenance of host-microbe mutualism. The fine-tuned relationship between the gut microbiota and host immunity is constantly challenged by opportunistic bacteria testing the integrity of gastrointestinal (GI) barrier defenses. Barrier dysfunction reduces immunological tolerance towards otherwise innocuous microbes; it is a process that may instigate chronic inflammation. Paradoxically, sustained inflammation further diminishes barrier function, enabling bacterial translocation to extra-intestinal tissues. Once translocated, these bacteria stimulate systemic inflammation, thereby compromising organ function. While genetic risk alleles associate with barrier dysfunction, environmental stressors are key triggers of GI inflammation and associated breakdown in immune tolerance towards resident gut microbes. As dietary components dictate substrate availability, they also orchestrate microbiota composition and function, including migratory and pro-inflammatory potential, thus holding the capacity to fuel both GI and extra-intestinal inflammation. Additionally, Western diet consumption may weaken barrier defenses via curbed Paneth cell function and diminished host-defense peptide secretion. This review focuses on intervenable niches of host-microbe interactions and mucosal immunity with the ambition to provide a framework of plausible strategies to improve barrier function and regain tolerance in the inflamed mucosa via nutritional intervention.

Citing Articles

Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow.

Robles-Vera I, Jarit-Cabanillas A, Brandi P, Martinez-Lopez M, Martinez-Cano S, Rodrigo-Tapias M Immunity. 2025; 58(2):381-396.e9.

PMID: 39848243 PMC: 11832192. DOI: 10.1016/j.immuni.2024.12.012.

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune Balance.

Pedrosa L, de Vos P, Fabi J Nutrients. 2025; 16(24.

PMID: 39770907 PMC: 11678351. DOI: 10.3390/nu16244286.

Prenatal and Early Life Exposure to Ambient Air Pollutants Is Associated with the Fecal Metabolome in the First Two Years of Life.

Holzhausen E, Chalifour B, Tan Y, Young N, Lurmann F, Jones D Environ Sci Technol. 2024; 58(32):14121-14134.

PMID: 39086199 PMC: 11325649. DOI: 10.1021/acs.est.4c02929.

When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.

Zhao X, Ju B, Xiu N, Sun X, Meng F Front Immunol. 2024; 15:1339971.

PMID: 38426096 PMC: 10902444. DOI: 10.3389/fimmu.2024.1339971.

Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.

Zou S, Yang C, Zhang J, Zhong D, Meng M, Zhang L J Transl Med. 2024; 22(1):175.

PMID: 38369542 PMC: 10874565. DOI: 10.1186/s12967-024-04984-4.

References

White S, Wimley W, Selsted M . Structure, function, and membrane integration of defensins. Curr Opin Struct Biol. 1995; 5(4):521-7. DOI: 10.1016/0959-440x(95)80038-7. View

Sabat R, Ouyang W, Wolk K . Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov. 2014; 13(1):21-38. DOI: 10.1038/nrd4176. View

Ohnmacht C, Park J, Cording S, Wing J, Atarashi K, Obata Y . MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells. Science. 2015; 349(6251):989-93. DOI: 10.1126/science.aac4263. View

Rowan F, Docherty N, Murphy M, Murphy B, Coffey J, OConnell P . Desulfovibrio bacterial species are increased in ulcerative colitis. Dis Colon Rectum. 2010; 53(11):1530-6. DOI: 10.1007/DCR.0b013e3181f1e620. View

Carlsen H, Haraldsen G, Brandtzaeg P, Baekkevold E . Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood. 2005; 106(2):444-6. DOI: 10.1182/blood-2004-11-4353. View

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

Ehmann D, Wendler J, Koeninger L, Larsen I, Klag T, Berger J . Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments. Proc Natl Acad Sci U S A. 2019; 116(9):3746-3751. PMC: 6397583. DOI: 10.1073/pnas.1817376116. View

Birchenough G, Nystrom E, Johansson M, Hansson G . A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science. 2016; 352(6293):1535-42. PMC: 5148821. DOI: 10.1126/science.aaf7419. View

Atreya R, Siegmund B . Location is important: differentiation between ileal and colonic Crohn's disease. Nat Rev Gastroenterol Hepatol. 2021; 18(8):544-558. DOI: 10.1038/s41575-021-00424-6. View

10.

Esterhazy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A . Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019; 569(7754):126-130. PMC: 6587593. DOI: 10.1038/s41586-019-1125-3. View

11.

Yang B, Hagemann S, Mamareli P, Lauer U, Hoffmann U, Beckstette M . Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 2015; 9(2):444-57. DOI: 10.1038/mi.2015.74. View

12.

Cadwell K, Liu J, Brown S, Miyoshi H, Loh J, Lennerz J . A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008; 456(7219):259-63. PMC: 2695978. DOI: 10.1038/nature07416. View

13.

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S . Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019; 25(7):1096-1103. PMC: 6699990. DOI: 10.1038/s41591-019-0495-2. View

14.

Jaeger S, Schroeder B, Meyer-Hoffert U, Courth L, Fehr S, Gersemann M . Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin. Mucosal Immunol. 2013; 6(6):1179-90. PMC: 3806438. DOI: 10.1038/mi.2013.17. View

15.

Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C . Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut. 2011; 61(1):78-85. PMC: 3230831. DOI: 10.1136/gutjnl-2011-300370. View

16.

Petnicki-Ocwieja T, Hrncir T, Liu Y, Biswas A, Hudcovic T, Tlaskalova-Hogenova H . Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A. 2009; 106(37):15813-8. PMC: 2747201. DOI: 10.1073/pnas.0907722106. View

17.

Tanoue T, Atarashi K, Honda K . Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 2016; 16(5):295-309. DOI: 10.1038/nri.2016.36. View

18.

Wendler J, Schroeder B, Ehmann D, Koeninger L, Mailander-Sanchez D, Lemberg C . Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide. Sci Rep. 2019; 9(1):3640. PMC: 6403363. DOI: 10.1038/s41598-019-40216-2. View

19.

Zheng Y, Valdez P, Danilenko D, Hu Y, Sa S, Gong Q . Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008; 14(3):282-9. DOI: 10.1038/nm1720. View

20.

Loddo I, Romano C . Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis. Front Immunol. 2015; 6:551. PMC: 4629465. DOI: 10.3389/fimmu.2015.00551. View